http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110128498-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-0026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00 |
| filingDate | 2019-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110128498-B |
| titleOfInvention | Diosgenin derivative, pharmaceutical composition thereof, preparation method and application thereof |
| abstract | The invention belongs to the technical field of medicines, and particularly relates to Diosgenin (Diosgenin) succinic acid 5-nitroisosorbide shown in a formula I, a pharmaceutical composition taking the compound as an active ingredient, a pancreatic lipase inhibitor taking the compound as an active ingredient, a preparation method of the compound, and application of the compound in preparation of medicines for preventing and treating hyperlipidemia. In-vitro activity experiments prove that the compound has higher in-vitro hypolipidemic activity, can be used for preparing medicines for treating or/and preventing hyperlipidemia, and provides a new solution and scheme for synthesis of other similar compounds. |
| priorityDate | 2019-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 85.